Showing 1751-1760 of 10609 results for "".
Inflamed Feelings: The Psychological Effects of Inflammatory Disorders
https://practicaldermatology.com/topics/psoriasis/PD0309_05-php/22859/Data suggest that children and adults suffering from chronic inflammatory skin diseases, such as eczema and psoriasis, are at higher risk for depression, anxiety, and other psychiatric illnesses.HPV and Genital Warts
https://practicaldermatology.com/topics/general-topics/hpv-and-genital-warts/20756/Combating the most common STD with vaccines and promising new treatments.Reimagining Melanoma Diagnosis with Genomic Analysis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/reimagining-melanoma-diagnosis-with-genomic-analysis/23484/A non-invasive test allows for genetic assessment of suspicious lesions.A Review of Complications of Biologic Therapy for Psoriasis
https://practicaldermatology.com/topics/general-topics/1109_02-php/22053/Therapeutic success requires clinicians to understand emerging and established safety concerns.Blinded by the Light—and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/blinded-by-the-lightand-more/23154/CSF faculty members share their favorite Energy- and Light-Based Devices.Patient Education: The Heart of Your Plan
https://practicaldermatology.com/topics/practice-management/patient-education-the-heart-of-your-plan/20928/Your office must be equipped with proper strategies to engage and educate if you want to make a lasting impression with your patients.PBM Restrictions Force Dermatologists to Consider OTC Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pbm-restrictions-force-dermatologists-to-consider-otc-products/23578/The latest generation of OTC products for some common dermatologic diseases often feature innovative formulations and clinical studies to show efficacy.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuGreat Expectations
https://practicaldermatology.com/topics/practice-management/great-expectations/20607/A look ahead to hot topics at Cosmetic Surgery Forum 2017Raising Issues with MOC
https://practicaldermatology.com/topics/practice-management/raising-issues-with-moc/21195/Dermatologists and the AAD speak out against current MOC requirements and suggest changes.